CAAS
RDY icon

Capital Asset Advisory Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Capital Asset Advisory Services’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,565
Closed -$22K – 1313
2020
Q4 		$22K Buy
+1,565
New +$21.1K ﹤0.01% 845

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Capital Asset Advisory Services's RDY Position: Q1 2021 in Review

Capital Asset Advisory Services sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 1,565 shares — an estimated $22K sold.

Capital Asset Advisory Services first reported a position in RDY in Q4 2020 and held it in 1 quarter. The position peaked at $22K in Q4 2020. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

  • Capital Asset Advisory Services reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
  • Capital Asset Advisory Services sold 1,565 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $22K.
  • Capital Asset Advisory Services first reported a position in Dr. Reddy's Laboratories in Q4 2020 and held it in 1 quarter.
  • Capital Asset Advisory Services's Dr. Reddy's Laboratories position peaked at $22K in Q4 2020.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.